AstraZeneca PLC (NYSE:AZN)

54.60
Delayed Data
As of May 29
 +1.10 / +2.06%
Today’s Change
36.15
Today|||52-Week Range
57.44
+9.51%
Year-to-Date
Dynavax Stock Soars 26.4% Today on COVID-19 Vaccine Hopes
May 29 / MotleyFool.com - Paid Partner Content
Health care stocks are solid, but some remain a big gamble
May 24 / CNN.com - Paid Partner Content
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
May 29 / MotleyFool.com - Paid Partner Content
U.S. Seals Deal with AstraZeneca for 300 Million Doses of Potential Coronavirus Vaccine
May 21 / MotleyFool.com - Paid Partner Content
At Last, Merck Is Diving Into Coronavirus Vaccine and Antiviral Development
May 26 / MotleyFool.com - Paid Partner Content
AstraZeneca CEO says $1 billion vaccine bet is 'absolutely worth it'
May 21 / CNN.com - Paid Partner Content
Oxford Professor Lowers Coronavirus Vaccine's Odds of Meeting September Deadline
May 24 / MotleyFool.com - Paid Partner Content
FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck
May 20 / MotleyFool.com - Paid Partner Content
If You'd Invested $10,000 in Moderna's IPO, Here's How Much Money You'd Have Now
May 24 / MotleyFool.com - Paid Partner Content
Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics
May 20 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Merck
May 24 / MotleyFool.com - Paid Partner Content